Detalles de la búsqueda
1.
Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide.
Scand J Rheumatol;
50(1): 11-14, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757870
2.
Teriparatide and exercise improve bone, skeletal muscle, and fat parameters in ovariectomized and tail-suspended rats.
J Bone Miner Metab;
39(3): 385-395, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392725
3.
Assessment of the efficacy of teriparatide treatment for osteoporosis on lumbar fusion surgery outcomes: a systematic review and meta-analysis.
Neurosurg Rev;
44(3): 1357-1370, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728969
4.
Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate.
Mod Rheumatol;
31(3): 733-742, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646253
5.
Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis.
Mod Rheumatol;
31(2): 485-492, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32412351
6.
Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.
Pharm Res;
37(4): 80, 2020 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253527
7.
Factors affecting continuation of weekly teriparatide administration in rural areas.
J Bone Miner Metab;
38(2): 248-253, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583539
8.
Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial.
J Bone Miner Metab;
38(3): 310-315, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707465
9.
The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice.
Oral Dis;
26(3): 609-620, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903673
10.
Regional improvements in lumbosacropelvic Hounsfield units following teriparatide treatment.
Neurosurg Focus;
49(2): E11, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738792
11.
Low acceptance of osteoanabolic therapy with parathyroid hormone in patients with fragility fracture of the pelvis in routine clinical practice: a retrospective observational cohort study.
Arch Orthop Trauma Surg;
140(3): 321-329, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31332508
12.
Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program.
Osteoporos Int;
30(9): 1837-1844, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321446
13.
A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis.
Osteoporos Int;
30(10): 2027-2037, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31243480
14.
Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study.
Osteoporos Int;
30(11): 2321-2331, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392401
15.
Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
Osteoporos Int;
30(11): 2349-2354, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31428823
16.
Optimal administration frequency and dose of teriparatide for acceleration of biomechanical healing of long-bone fracture in a mouse model.
J Bone Miner Metab;
37(2): 256-263, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29721806
17.
Impact of vitamin C on teriparatide treatment in the improvement of bone mineral density, strength, and quality in vitamin C-deficient rats.
J Bone Miner Metab;
37(3): 411-418, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014298
18.
Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States.
Ann Pharmacother;
53(2): 134-143, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30160186
19.
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies.
Bull Math Biol;
81(9): 3575-3622, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30460589
20.
A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report.
J Am Pharm Assoc (2003);
59(4): 593-597, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31101442